India, April 24 -- A study published recently in the Frontiers in Psychiatry journal by Kehuang Li et al linked the occurrence of dyslipidemia with early onset schizophrenia in children and adolescents.
Early-onset schizophrenia (EOS) is a rare psychological disease that manifests before adulthood, or 18 years of age. It accounts for 4% of all schizophrenia cases, and has posed significant therapeutic challenges in the past.
EOS is treated by regimes of antipsychotic medications, unwanted side-effects of which can lead to patients becoming overweight, obese, or developing dyslipidemia, which is characterized by abnormal levels of fat in the blood. In the long-term, dyslipidemia can cause significant cardiovascular or cerebrovascular disea...